GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Kukje Pharma Co Ltd (XKRX:002720) » Definitions » Cash From Other Investing Activities

Kukje Pharma Co (XKRX:002720) Cash From Other Investing Activities : ₩-1,993 Mil (TTM As of Mar. 2025)


View and export this data going back to 1975. Start your Free Trial

What is Kukje Pharma Co Cash From Other Investing Activities?

Cash from other investing activities means the cash received by a company that comes from other investing activities.

Kukje Pharma Co's cash from other investing activities for the three months ended in Mar. 2025 was ₩9 Mil. It means Kukje Pharma Co received ₩9 Mil from other investing activities. Kukje Pharma Co's cash from other investing activities for the trailing twelve months (TTM) ended in Mar. 2025 was ₩-1,993 Mil.

Kukje Pharma Co Cash From Other Investing Activities Historical Data

The historical data trend for Kukje Pharma Co's Cash From Other Investing Activities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kukje Pharma Co Cash From Other Investing Activities Chart

Kukje Pharma Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cash From Other Investing Activities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4,359.45 -83.05 -151.54 -354.90 -207.63

Kukje Pharma Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cash From Other Investing Activities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 43.13 153.27 -1,829.75 -325.55 9.06

Kukje Pharma Co Cash From Other Investing Activities Calculation

Cash from other investing activities means the cash received by a company that comes from other investing activities.

Cash From Other Investing Activities for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩-1,993 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Kukje Pharma Co Cash From Other Investing Activities Related Terms

Thank you for viewing the detailed overview of Kukje Pharma Co's Cash From Other Investing Activities provided by GuruFocus.com. Please click on the following links to see related term pages.

Kukje Pharma Co Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Kukje Pharma Co Ltd (XKRX:002720) » Definitions » Cash From Other Investing Activities
Comparable Companies
XKRX:072020 XKRX:054670 XKRX:204840 XKRX:131030 XKRX:002800 XKRX:004310 XKRX:229500 XKRX:142280 XKRX:183490 XKRX:041910 ZTS XTER:MRK LSE:HLN NSE:SUNPHARMA TSE:4502 XSWX:GALD XSWX:SDZ NSE:DIVISLAB HKSE:03692 XTAE:TEVA
Traded in Other Exchanges
N/A
Address
96-8 Yatapiro, Bundang-Gu, Seongnam-si, Gyeonggi, KOR, 463-839
Website
http://www.kukjepharm.co.kr
Kukje Pharma Co Ltd engages in manufacturing, importing, exporting, selling, and distributing pharmaceutical products internationally. The company offers pharmaceutical products, including ETC and OTC products, raw materials, intermediates, and side chain products, as well as cosmetics and health care products. Its products include cephalosporins, penicillins, quinolones, aminoglycosides, macrolides, antifungal and antiviral agents, and other antibiotics.

Kukje Pharma Co Headlines

No Headlines